Santhera Pharmaceuticals Receives U.S. FDA Approval of Agamree ... - Marketscreener.com

SPHDF Stock  USD 9.42  0.00  0.00%   
Roughly 67% of Santhera Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Santhera Pharmaceuticals Holding pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Santhera Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Santhera Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Santhera Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Santhera daily returns and investor perception about the current price of Santhera Pharmaceuticals Holding as well as its diversification or hedging effects on your existing portfolios.
  
Santhera Pharmaceuticals Receives U.S. FDA Approval of Agamree ... Marketscreener.com

Read at news.google.com
Google News at Macroaxis
  

Santhera Pharmaceuticals Fundamental Analysis

We analyze Santhera Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Santhera Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Santhera Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Santhera Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Santhera Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Santhera Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Santhera Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Santhera Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Santhera Pharmaceuticals Related Equities

ANABAnaptysBio   4.79   
0%
91.0%
IVAInventiva   1.85   
0%
35.0%
ACHLAchilles Therapeutics   1.75   
0%
33.0%
GNFTGenfit   1.60   
0%
30.0%
ZVSAZyVersa Therapeutics   0.81   
0%
15.0%
GHRSGH Research   0.33   
6.0%
0%
BDRXBiodexa Pharmaceticals   1.11   
21.0%
0%
IDYAIdeaya Biosciences   1.19   
22.0%
0%
MGTXMeiraGTx Holdings   1.25   
23.0%
0%
KROSKeros Therapeutics   2.86   
54.0%
0%
LEXXLexaria Bioscience   4.80   
91.0%
0%
DSGNDesign Therapeutics   5.26   
100.0%
0%

Complementary Tools for Santhera Pink Sheet analysis

When running Santhera Pharmaceuticals' price analysis, check to measure Santhera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santhera Pharmaceuticals is operating at the current time. Most of Santhera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Santhera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santhera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Santhera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account